HIV/AIDS | The Global Health Delivery Project at Harvard University

Dr. Rachel Vreeman, Co-Director of Pediatric Research for AMPATH

I recently had the pleasure of speaking with Dr. Rachel Vreeman, Assistant professor of Pediatrics at Indiana University School of Medicine, and Co-Director of Pediatric Research for AMPATH, about the challenges of pediatric ART adherence.

Dr. Vreeman was kind enough to answer a few questions about her work in Kenya with AMPATH and has expanded on some of her responses in the video at the end of this post. She will also be fielding questions about pediatric ART adherence in GHDonline’s Adherence and Retention community next week, from April 9th to the 13th. Please sign up for GHDonline now to join this discussion!

Continue reading →

… that “an AIDS-free generation is possible.” Armed with growing evidence supporting pre-exposure prophylaxis (PrEP), a.k.a. “treatment as prevention”, President Obama yesterday made this statement and pledged increased support along the way, setting a new target of helping 6 million people get treatment by the end of 2013, upping the current number by 2 million.

Raising awareness and hope for HIV/AIDS in Uganda

There is good reason to believe. On December 1, world leaders and organizations marked World AIDS Day, which was themed “Getting to Zero” (in-line with the UNAIDS strategy). Thirty years into the epidemic, over 65 million people have been infected with the human immunodeficiency virus (HIV), over 30 million have died, and there are currently 34 million people living with HIV/AIDS worldwide as Jennifer Weinberg recaps in the Global Pulse Journal Blog. Among major milestones, the overall continued decrease in rate of new infections, deaths, and ART cost are paramount (see the UNAIDS World AIDS Day Report 2011 for more details – PDF).

Continue reading →